BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 31710397)

  • 1. Cerebrolysin for vascular dementia.
    Cui S; Chen N; Yang M; Guo J; Zhou M; Zhu C; He L
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31710397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrolysin for vascular dementia.
    Chen N; Yang M; Guo J; Zhou M; Zhu C; He L
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008900. PubMed ID: 23440834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Hoyle CH
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007026. PubMed ID: 32662068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Nurkhametova D; Ivanchenko K
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD007026. PubMed ID: 37818733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids for the treatment of dementia.
    Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids for the treatment of dementia.
    Bosnjak Kuharic D; Markovic D; Brkovic T; Jeric Kegalj M; Rubic Z; Vuica Vukasovic A; Jeroncic A; Puljak L
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012820. PubMed ID: 34532852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galantamine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive withdrawal for the prevention of cognitive decline.
    Jongstra S; Harrison JK; Quinn TJ; Richard E
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011971. PubMed ID: 27802359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
    Gates NJ; Rutjes AW; Di Nisio M; Karim S; Chong LY; March E; Martínez G; Vernooij RW
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012277. PubMed ID: 32104914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Vernay L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007026. PubMed ID: 28430363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personally tailored activities for improving psychosocial outcomes for people with dementia in long-term care.
    Möhler R; Renom A; Renom H; Meyer G
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD009812. PubMed ID: 29438597
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.